RNA was collected from cancer cell lines(EVSA-T, LnCAP, HCC-70 and ZR-75-1) expressing Cas9 for RNA-seq. RNA expression profiles will be compared to the parental cell lines from which the Cas9 clones
pESCs hold significant potential for applications in regenerative medicine and stem cell-based breeding programs. However, the regulatory mechanisms governing pluripotency in pESCs, including aspects
SORSC1 gene editing by CRISPR-Cas9 nuclease in heterozygous HFF for UROS inactivation. Fluorescent positive cell sorting for UROS and large rearrangements confirmation in chromosome 10q. One condition